106
Participants
Start Date
November 30, 2005
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
ceftobiprole plus placebo
ceftobiprole 500 mg every 8 hours as a 120 minute intravenous infusion and placebo administered every 12 hours as a 60-minute intravenous infusion for 7 to 14 days
linezolid plus ceftazidime
linezolid 600 mg every 12 hours as a 60-minute intravenous infusion plus ceftazidime 2 g every 8 hours as a 120-minute intravenous infusion for 7 to 14 days
Lead Sponsor
Basilea Pharmaceutica
INDUSTRY